DexCom Inc (DXCM)
NASDAQ · Healthcare · Medical Devices
DexCom Inc is a Healthcare company with a market capitalization of $27.07B and a trailing P/E ratio of 30.1.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $0.56 | $0.47 | +19.1% |
| Q4 2025 | February 12, 2026 | $0.68 | $0.65 | +4.6% |
| Q3 2025 | October 30, 2025 | $0.61 | $0.57 | +7.0% |
| Q2 2025 | July 30, 2025 | $0.48 | $0.44 | +9.1% |
| Q1 2025 | May 1, 2025 | $0.32 | $0.33 | -3.0% |
| Q4 2024 | February 13, 2025 | $0.45 | $0.50 | -10.0% |
Other Medical Devices Stocks
Frequently Asked Questions
What is DexCom Inc's market cap?
As of June 29, 2026, DexCom Inc (DXCM) has a market capitalization of $27.07B.
What is DexCom Inc's P/E ratio?
DexCom Inc trades at a trailing price-to-earnings (P/E) ratio of 30.1. Its forward P/E is 26.8.
Does DexCom Inc pay a dividend?
DexCom Inc does not currently pay a dividend.
What sector is DXCM in?
DexCom Inc is in the Healthcare sector, specifically the Medical Devices industry.
What was DexCom Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), DexCom Inc reported revenue of $4.66B and net income of $836.30M.
Ask your own questions about DXCM
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.